Is Patheon owned by Thermo Fisher?
In August 2017, Thermo Fisher Scientific completed the acquisition of Patheon, creating the world’s most comprehensive and sophisticated end-to-end CDMO partner. One year later, Thermo Fisher’s Pharma Services is delivering integrated drug development and clinical trial services to clients across the globe.
Is Patheon a CMO?
“We believe we are the world’s third-largest CMO provider and the world’s largest PDS provider,” Patheon said in the preliminary proxy statement, based on calendar year 2011 revenues provided by outsourcing market intelligence group PharmSource.
Who owns Patheon Pharmaceuticals?
Thermo Fisher Scientific
JLL/Delta Patheon HoldingsThermo Fisher Scientific (Panama) B.V.
Patheon/Parent organizations
Thermo Fisher Scientific is acquiring Patheon, which has been at the center of the consolidation that has swept through contract manufacturing in recent years, in a deal valued at $7.2 billion.
What is Patheon manufacturing?
Patheon Manufacturing Services LLC operates as a pharmaceutical company. The Company offers nutritional, diagnostic, vascular, and diabetes care products. Patheon Manufacturing Services serves customers worldwide.
Why did Thermo Fisher buy Patheon?
N said on Monday it would buy Patheon NV PTHN. N, a Dutch manufacturer of drugs for clinical trials, for $5.2 billion as it seeks to complement its offerings in production and services for the biopharma industry. The offer price of $35 per share represents a premium of about 35 percent to Patheon’s Friday close.
Is patheon a Cdmo?
Patheon N.V. is a pharmaceutical contract development and manufacturing organization (CDMO) headquartered in Amsterdam and Durham, North Carolina, United States. In 2014, Patheon merged with the drug manufacturing business of Royal DSM NV, becoming a joint-venture between JLL Partners and DSM.
Is patheon a public company?
It was founded in 1974 as Custom Pharmaceuticals Ltd., and changed its name to Patheon in 1993 when it was first publicly traded….Patheon.
| Type | Subsidiary |
|---|---|
| Industry | Contract pharmaceutical services |
| Headquarters | Amsterdam, Netherlands Durham, North Carolina, U.S. |
Who is Thermo Fisher competitors?
Thermo Fisher Scientific competitors include Agilent Technologies, Bruker Corporation, Beckman Coulter and Bio-Rad Laboratories.
What is a Cdmo in pharma?
A contract development and manufacturing company (CDMO) is a company within the pharmaceutical industry that provides drug development and manufacturing services. Pharmaceutical companies partner with CDMOs as a way to outsource drug development and drug manufacturing.
What is Mark Casper salary?
Executive Compensation As Chairman, President and Chief Executive Officer at THERMO FISHER SCIENTIFIC INC., Marc N. Casper made $19,023,145 in total compensation.
What do you need to know about Patheon?
From route scouting to analytical development & validation, our experts pride themselves on solving your small molecule API development challenges. We offer comprehensive development and clinical manufacturing services for biologics, ranging from cell line development to cold storage and distribution.
Is Thermo Fisher Scientific part of Patheon?
Our Fisher Clinical Services SM offerings are now part of the Patheon brand portfolio by Thermo Fisher Scientific. Please update your bookmark. Responding to critical market capacity constraints, Thermo Fisher announces the official opening of new 67,000 sqft cGMP plasmid DNA manufacturing facility in Carlsbad, CA.
Where are the Patheon manufacturing sites in the world?
Over the next two years, expansion projects at our sites in Greenville, NC, Ferentino and Monza, Italy, and Swindon, UK, will add 15 development and commercial production lines to support a range of capabilities, including live virus, aseptic liquid and lyophilized vial filling, to further enhance our global steriles network.
What can Patheon plasmid DNA be used for?
The new site will expand the company’’s clinical and commercial capabilities for cGMP plasmid DNA used as a critical raw material to develop and manufacture cell and gene-based therapies including life-saving cancer treatments and mRNA vaccines.